- Home
- VYGR vs BRT Comparison
VYGR vs BRT Comparison
Compare VYGR & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- BRT
- Stock Information
- Founded
- VYGR 2013
- BRT 1972
- Country
- VYGR United States
- BRT United States
- Employees
- VYGR N/A
- BRT N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- VYGR Health Care
- BRT Real Estate
- Exchange
- VYGR Nasdaq
- BRT Nasdaq
- Market Cap
- VYGR 342.5M
- BRT 330.2M
- IPO Year
- VYGR 2015
- BRT N/A
- Fundamental
- Price
- VYGR $5.22
- BRT $17.44
- Analyst Decision
- VYGR Strong Buy
- BRT Strong Buy
- Analyst Count
- VYGR 9
- BRT 3
- Target Price
- VYGR $15.53
- BRT $22.17
- AVG Volume (30 Days)
- VYGR 361.6K
- BRT 38.6K
- Earning Date
- VYGR 02-26-2025
- BRT 03-11-2025
- Dividend Yield
- VYGR N/A
- BRT 5.75%
- EPS Growth
- VYGR N/A
- BRT N/A
- EPS
- VYGR 0.47
- BRT N/A
- Revenue
- VYGR $163,784,000.00
- BRT $96,743,000.00
- Revenue This Year
- VYGR N/A
- BRT N/A
- Revenue Next Year
- VYGR N/A
- BRT $5.73
- P/E Ratio
- VYGR $11.19
- BRT N/A
- Revenue Growth
- VYGR 3.40
- BRT 1.95
- 52 Week Low
- VYGR $4.99
- BRT $15.21
- 52 Week High
- VYGR $10.66
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- VYGR 38.79
- BRT 43.85
- Support Level
- VYGR $4.99
- BRT $16.66
- Resistance Level
- VYGR $5.45
- BRT $17.84
- Average True Range (ATR)
- VYGR 0.26
- BRT 0.48
- MACD
- VYGR -0.05
- BRT 0.04
- Stochastic Oscillator
- VYGR 17.97
- BRT 46.71
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.